行情

TTPH

Tetraphase制药
TTPH
NASDAQ
已退市
市盈率(FWD)
市销率
市净率
市值
-0.0963
1.320
0.5817
15,979,119.20
新闻
财报
公告
公司事件
分析
简况
新股消息丨临床后期生物制药公司云顶新耀过聆讯 开发药物覆盖肿瘤、免疫学、心肾疾病及感染性疾病
智通财经网 · 2020/09/20 23:55
The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy
Benzinga · 2020/06/25 13:26
The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24)
Benzinga · 2020/06/25 12:26
Tetraphase Terminated Deal With Melinta
Benzinga · 2020/06/24 11:38
UPDATE: Total Value Of La Jolla Purchase Of Tetraphase $43M In Upfront Cash Plus Potential Future Cash Payments Of Up To $16M
Benzinga · 2020/06/24 11:33
UPDATE: Tetraphase Shareholders Will Be Entitled To Receive 1 Non-Tradeable Contingent Value Right
Tetraphase equity holders would also be entitled to receive, for each share of Tetraphase common stock, one non-tradeable CVR. The holders of the CVRs would be entitled to receive payments of up to an additional $16.0
Benzinga · 2020/06/24 11:32
La Jolla Pharma To Purchase Tetraphase Pharma For Upfront Payment Of $2/Share Of Tetraphase Common Stock, $2.68/Share Of Tetraphase Stock Underlying Nov. 2019 Warrants , $2.69/Share Tetraphase Stock Underlying Jan. 2020 Warrants
Benzinga · 2020/06/24 11:31
La Jolla Pharmaceutical Rekindles Interest In Tetraphase With Sweetened Offer
Benzinga · 2020/06/22 17:14
更多
财务预测
每股收益每股净资产每股现金流
实际值(美元)
预测值(美元)
利润表更多
净利润营业总收入营业利润
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流投资现金流筹资现金流
经营现金流(美元)
同比(%)
了解TTPH最新的财务预测,通过TTPH每股收益,每股净资产,每股现金流等数据分析Tetraphase制药近期的经营情况,然后做出明智的投资选择。
分析师评级

2位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测TTPH价格均价为1.500,最高价位1.500,最低价为1.500。
EPS
机构持股
总机构数: 45
机构持股: 525.90万
持股比例: 72.41%
总股本: 726.32万
类型机构数股数
增持
8
131.17万
建仓
15
107.19万
减持
2
5,269
平仓
0
0
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
-0.30%
制药与医学研究
-0.53%
高管信息
Chairman/Independent Director
Leonard Patrick Gage
President/Chief Executive Officer/Director
Larry Edwards
Senior Vice President - Finance
Christopher Watt
Senior Vice President/General Counsel
Maria Stahl
Chief Scientific Officer
Jacques Dumas
Vice President
Larry Tsai
Director
Steven Boyd
Director
Guy Macdonald
Director
Keith Maher
Independent Director
Garen Bohlin
Independent Director
Jeffrey Chodakewitz
Independent Director
John Freund
Independent Director
Geraldine Henwood
Independent Director
Nancy Wysenski
  • 分红
  • 拆股
  • 内部人交易
暂无数据
注册即可获得3个月
免费美股Level2深度行情
(Nasdaq Totalview)
立即领取

微牛提供Tetraphase制药(NASDAQ-TTPH)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的TTPH股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易TTPH股票基本功能。